Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease ...

As cases of chronic kidney disease emerge in outdoor laborers around the world, scientists are finding that repeated damage ...

Finerenone (Kerendia) is thought to work by inhibiting inflammation that can cause kidney damage, according to Drugs.com. The ...

A new genetic study on the causes of chronic kidney disease that combined multiple health measurements has led to a more ...

Chronic kidney disease (CKD) affects millions worldwide. It is a long-term condition where the kidneys do not work as well as ...

For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary albumin-to-creatinine ratio than either agent alone, ...

Korea's Beringer Ingelheim recently held an event for executives and employees '60 seconds to show kidney health' As part of ...

Trial results offer clinically important information on the efficacy and safety of the combination therapy in CKD with type 2 diabetes.

China: A recent study published in Reviews in Cardiovascular Medicine highlights the significance of left atrial structural ...

Early detection and new biomarkers are changing how we manage acute kidney injury—and its link to chronic kidney disease.

It’s the silent, progressive disease that slowly is killing millions of Australians – but most don’t know they have it.